Efficacy and safety of nedocromil sodium ophthalmic solution in the treatment of seasonal allergic conjunctivitis.
Explore this paper's citation graph
Summary
It is concluded that nedocromil sodium 2% ophthalmic solution administered twice daily is effective in relieving major symptoms associated with seasonal allergic conjunctivitis.
- Type
- article
- Published
- 1992-01-01
- Cited by
- 50
- References
- 11
- Access
- Open access
- OpenAlex
- https://openalex.org/W1309410
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:19997371
Keywords
Art
References
- Double-blind group comparative study of 2% nedocromil sodium eye drops with placebo eye drops in the treatment of seasonal allergic conjunctivitis.
- The pharmacokinetics of nedocromil sodium, a new drug for the treatment of reversible obstructive airways disease, in human volunteers and patients with reversible obstructive airways disease.
- Effectiveness of nedocromil sodium versus placebo as additions to routine asthma maintenance therapy: a multicentre, double-blind, group comparative trial.
- Sodium cromoglycate in ragweed-allergic conjunctivitis.
- Chi-square tests with one degree of freedom
- Human conjunctival mast cells: distribution of MCT and MCTC in vernal conjunctivitis and giant papillary conjunctivitis.
- Nedocromil sodium: a new drug for the management of bronchial asthma.
- Ocular allergy and mast cell stabilizers.
- Treatment of ragweed allergic conjunctivitis with cromolyn sodium 4% ophthalmic solution.
- A Double-Blind Group Comparative Trial of Nedocromil Sodium and Placebo in the Management of Bronchial Asthma
Cited by
- The treatment of allergic eye disease: has sodium cromoglycate had its day?
- Nedocromil sodium and astemizole, alone or combined, in the treatment of seasonal allergic conjunctivitis
- Therapeutic Options in Ocular Allergic Disease
- Treatment of ocular allergies: nonpharmacologic, pharmacologic and immunotherapy
- Treatment of ragweed pollen seasonal allergic conjunctivitis (SAC) with b.i.d. nedocromil sodium 2% ophthalmic solution.
- Nedocromil sodium 2% ophthalmic solution (Tilavist(TM)) A new topical treatment for ocular allergic inflammation.
- Ocular allergy treatment.
- Update on ocular allergy treatment
- Evaluation of olopatadine, a new ophthalmic antiallergic agent with dual activity, using the conjunctival allergen challenge model.
- Supplementation of fexofenadine therapy with nedocromil sodium 2% ophthalmic solution to treat ocular symptoms of seasonal allergic conjunctivitis
- Allergic and immunologic disorders of the eye. Part II: ocular allergy.
- A controlled evaluation of the efficacy and safety of loteprednol etabonate in the prophylactic treatment of seasonal allergic conjunctivitis. Loteprednol Allergic Conjunctivitis Study Group.
- Ocular allergic disease: mechanisms, disease sub-types, treatment.
- Nedocromil sodium ophthalmic solution 2% twice daily in patients with allergic conjunctivitis
- The Pathophysiology of Ocular Allergy: Current Thinking
- Emerging drugs for ocular allergy
- Allergic eye disease mechanisms
- Expression of ICAM-1 and HLA-DR by Human Conjunctival Epithelial Cultured Cells and Modulation by Nedocromil Sodium
- Twice-daily and once-daily nedocromil sodium 2% ophthalmic solution for the treatment of seasonal allergic conjunctivitis
- Topical immunopharmacology of ocular allergies
Related papers
No related papers recorded.